This symposium will focus on the use of heparin management strategies to optimize patient outcomes via multiple testing techniques. Implementation of Anti-Xa testing for heparin monitoring and heparin-related complications will be covered.

Following the workshop, Werfen representatives will be available online to answer questions.

Date

This event took place on October 24, 2023 and is now available on-demand.

Times

To accommodate time zones around the world, this program is offered at multiple times, in English. When registering, please select the time that best accommodates your schedule.

11:00 AM–2:00 PM ET
7:00 PM–10:00 PM ET

Objectives

• Define the benefits of Anti-Xa testing for heparin monitoring.
• Highlight the health-economic benefits of Anti-Xa versus aPTT testing for heparin monitoring.
• Discuss the diagnosis and management of heparin-induced thrombocytopenia, with case examples.

Speakers

Deepa Jayakody Arachchillage, MD, MBBS, MRCP, FRCPath
Imperial College London; Hammersmith Hospital, London, England

​
K. Maria Notini, MT (ASCP)
Duke University Medical Center, Durham, NC, US

 ​
Ted E. Warkentin, MD, BSc(Med), FRCP(C), FACP
McMaster University; Hamilton General Hospital, Hamilton, ON, Canada

 ​
Annie Winkler, MD
Werfen, Bedford, MA, US